Gilead is, rightfully, under attack for their disgusting Descovy HIV RX commercials. It's on Youtube, I'm not linking to it.

But Gilead has bigger problems.

The New York Times has, of course, advocated for more "diverse" advertising

.

https://www.nytimes.com/2013/06/26/business/media/commercials-with-a-gay-emphasis-are-moving-to-mainstream-media.html

Gilead has a history of illegally profiting from taxpayer research.

(snip)

But the company's work in the PrEP has also stirred up controversy. Last year, the U.S. government accused Gilead of illegally profiting from taxpayer-funded HIV research, saying work done by the Centers for Disease Control and Prevention was critical in establishing the PrEP use of Gilead's medicines.

Gilead has also come under fire for the cost of its treatments. Truvada's price tag is now about $1,800 a month, more than twice its cost in 2004. Gilead sells Descovy at a similar price point but contends the successor medicine is a safer alternative.

https://www.biopharmadive.com/news/gilead-descovy-ad-campaign-switch-truvada-prep/572208/